Effects of Phlebotomy for the Japanese patients with NAFLD
Not Applicable
- Conditions
- AFLD
- Registration Number
- JPRN-UMIN000014142
- Lead Sponsor
- Osaka City Juso Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Serum ferritin < 20 ng/ml or Hb < 11 g/dl 2. Patients who had any other liver disease (such as acute hepatitis, exacerbation of chronic hepatitis), cirrhosis (Child B or C), or hepatocellular carcinoma. 3. Pregnant women or women who suspected of being pregnant. 4. Patients who attending physician judged as being inappropriate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ALT
- Secondary Outcome Measures
Name Time Method CBC biochemical test (gamma-GTP, LDL-C, HDL-C, TG, FBS, UA, IRI, HOMA-IR, Fe, Ferritin) Body fat measurement by CT Body measurement Body composition analysis